Session

PP 05 IBD (Posters)

SHOULD WE PERFORM ROUTINE TRANSIENT ELASTOGRAPHY (FIBROSCAN®) TO ASSES LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? (ONGOING STUDY)
SHOULD WE PERFORM ROUTINE TRANSIENT ELASTOGRAPHY (FIBROSCAN®) TO ASSES LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? (ONGOING STUDY)

TIME TO INFLAMMATORY BOWEL DISEASE DIAGNOSIS FOR PATIENTS PRESENTING WITH ABDOMINAL SYMPTOMS IN PRIMARY CARE AND ASSOCIATION WITH EMERGENCY HOSPITAL ADMISSION AND SURGERY; A RETROSPECTIVE COHORT STUDY
TIME TO INFLAMMATORY BOWEL DISEASE DIAGNOSIS FOR PATIENTS PRESENTING WITH ABDOMINAL SYMPTOMS IN PRIMARY CARE AND ASSOCIATION WITH EMERGENCY HOSPITAL ADMISSION AND SURGERY; A RETROSPECTIVE COHORT STUDY

PREDICTIVE FACTORS FOR RECOURSE TO SURGERY IN CROHN'S DISEASE
PREDICTIVE FACTORS FOR RECOURSE TO SURGERY IN CROHN'S DISEASE

THE ADMINISTRATION OF MM-MIR-378A-3P EXACERBATES CHRONIC INFLAMMATION AND FIBROSIS IN A MURINE INTESTINAL MODEL
THE ADMINISTRATION OF MM-MIR-378A-3P EXACERBATES CHRONIC INFLAMMATION AND FIBROSIS IN A MURINE INTESTINAL MODEL

THE EFFECTS OF QINGCHANG WENZHONG DECOCTION ON TISSUE-RESIDENT MEMORY CD4+T CELLS IN MICE WITH ULCERATIVE COLITIS
THE EFFECTS OF QINGCHANG WENZHONG DECOCTION ON TISSUE-RESIDENT MEMORY CD4+T CELLS IN MICE WITH ULCERATIVE COLITIS

ANTI-TNF AGENTS AND VEDOLIZUMAB HAVE SIMILAR SAFETY AS FIRST-LINE BIOLOGIC TREATMENT OF ELDERLY PATIENTS WITH ULCERATIVE COLITIS
ANTI-TNF AGENTS AND VEDOLIZUMAB HAVE SIMILAR SAFETY AS FIRST-LINE BIOLOGIC TREATMENT OF ELDERLY PATIENTS WITH ULCERATIVE COLITIS

PREVALENCE OF SURGERY IN PATIENTS WITH CROHN’S DISEASE IN AUSTRIA – A NATIONWIDE RETROSPECTIVE STUDY FROM 2011 THROUGH 2019
PREVALENCE OF SURGERY IN PATIENTS WITH CROHN’S DISEASE IN AUSTRIA – A NATIONWIDE RETROSPECTIVE STUDY FROM 2011 THROUGH 2019

IDENTIFICATION OF URINE AND SERUM DIAGNOSTIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE USING A PROTEOMIC APPROACH
IDENTIFICATION OF URINE AND SERUM DIAGNOSTIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE USING A PROTEOMIC APPROACH

ANALYSIS OF INTESTINAL TISSUE FROM NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE REVEALS DISTINCT PROTEOMIC PROFILES
ANALYSIS OF INTESTINAL TISSUE FROM NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE REVEALS DISTINCT PROTEOMIC PROFILES

RELATION BETWEEN SERUM INTERLEUKIN 33 CONCENTRATION, DEPRESSIVE SYMPTOMS AND SLEEP QUALITY IN INFLAMMATORY BOWEL DISEASE
RELATION BETWEEN SERUM INTERLEUKIN 33 CONCENTRATION, DEPRESSIVE SYMPTOMS AND SLEEP QUALITY IN INFLAMMATORY BOWEL DISEASE

LONG-TERM OUTCOMES OF ORAL ANTIBIOTICS COMBINATION THERAPY FOR INDUCTION AND MAINTENANCE OF ULCERATIVE COLITIS
LONG-TERM OUTCOMES OF ORAL ANTIBIOTICS COMBINATION THERAPY FOR INDUCTION AND MAINTENANCE OF ULCERATIVE COLITIS

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE
EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

ASSESSING THE EVOLVING NUANCES OF JAK INHIBITOR PRESCRIPTION IN ULCERATIVE COLITIS (UC) PATIENTS
ASSESSING THE EVOLVING NUANCES OF JAK INHIBITOR PRESCRIPTION IN ULCERATIVE COLITIS (UC) PATIENTS

EXAMINING MENTAL HEALTH DISEASE BURDEN AMONG CROHN’S DISEASE (CD) PATIENTS IN EUROPE
EXAMINING MENTAL HEALTH DISEASE BURDEN AMONG CROHN’S DISEASE (CD) PATIENTS IN EUROPE

IMMUNOLOGICAL EFFECTS OF HEPATITIS B VIRUS VACCINATION IN INFLAMMATORY BOWEL DISEASE PATIENTS
IMMUNOLOGICAL EFFECTS OF HEPATITIS B VIRUS VACCINATION IN INFLAMMATORY BOWEL DISEASE PATIENTS

NEOPLASIA CHARACTERISATION IN IBD COLON: AN INTERNATIONAL MULTI-CENTRE STUDY OF ENDOSCOPIST PERFORMANCE AND A GENERIC COLON CADX ALGORITHM PERFORMANCE
NEOPLASIA CHARACTERISATION IN IBD COLON: AN INTERNATIONAL MULTI-CENTRE STUDY OF ENDOSCOPIST PERFORMANCE AND A GENERIC COLON CADX ALGORITHM PERFORMANCE

INVESTIGATING THE EVOLUTION OF THE TREATMENT ALGORITHM OF ULCERATIVE COLITIS PATIENTS
INVESTIGATING THE EVOLUTION OF THE TREATMENT ALGORITHM OF ULCERATIVE COLITIS PATIENTS

CADE-IBD: A REALITY OR A DREAM? PROSPECTIVE EVALUATION OF A NOVEL NEURAL NETWORK FOR DETECTION OF NEOPLASIA IN IBD COLON
CADE-IBD: A REALITY OR A DREAM? PROSPECTIVE EVALUATION OF A NOVEL NEURAL NETWORK FOR DETECTION OF NEOPLASIA IN IBD COLON

EFFECTS OF ANTI-TNF AND ANTI-INTERLEUKINS 12 AND 23 DRUGS ON CIRCULATING DENDRITIC CELLS MIGRATORY CAPACITY IN INFLAMMATORY BOWEL DISEASE
EFFECTS OF ANTI-TNF AND ANTI-INTERLEUKINS 12 AND 23 DRUGS ON CIRCULATING DENDRITIC CELLS MIGRATORY CAPACITY IN INFLAMMATORY BOWEL DISEASE

URINARY LITHOGENIC PROFILE AND GUT AND URINARY MICROBIOTA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
URINARY LITHOGENIC PROFILE AND GUT AND URINARY MICROBIOTA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Item 581 - 600 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
30
31 32 33 34 35 36 37 38 39 40 41 42